anti s100β 8b10 antibody Search Results


anti s100β 8b10 antibody  (HyTest)
94
HyTest anti s100β 8b10 antibody
Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and <t>S100β)</t> within 15 min is highly desirable, in order to shorten the classification time.
Anti S100β 8b10 Antibody, supplied by HyTest, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+s100%CE%B2+8b10+antibody/Anti-RSV/pmc06603756-91-4-11
Average 94 stars, based on 1 article reviews
anti s100β 8b10 antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
s100β protein  (HyTest)
94
HyTest s100β protein
Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and <t>S100β)</t> within 15 min is highly desirable, in order to shorten the classification time.
S100β Protein, supplied by HyTest, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+s100%CE%B2+8b10+antibody/S100%2C+bb%2Bab%2C+bovine/pmc06603756-91-0-11
Average 94 stars, based on 1 article reviews
s100β protein - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
anti s100β 8b10 antibody  (Biorbyt)
96
Biorbyt anti s100β 8b10 antibody
Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and <t>S100β)</t> within 15 min is highly desirable, in order to shorten the classification time.
Anti S100β 8b10 Antibody, supplied by Biorbyt, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+s100%CE%B2+8b10+antibody/antibody/pm32113554-100-13-11
Average 96 stars, based on 1 article reviews
anti s100β 8b10 antibody - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

Image Search Results


Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and S100β) within 15 min is highly desirable, in order to shorten the classification time.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and S100β) within 15 min is highly desirable, in order to shorten the classification time.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques: Biomarker Discovery

Stroke biomarkers measurement using bold SPR chip. ( A ) NT-proBNP; ( B ) S100β.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Stroke biomarkers measurement using bold SPR chip. ( A ) NT-proBNP; ( B ) S100β.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques:

Validation in spiked plasma samples. ( A ) NT-proBNP; ( B ) S100β.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Validation in spiked plasma samples. ( A ) NT-proBNP; ( B ) S100β.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques: Biomarker Discovery, Clinical Proteomics

Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and S100β) within 15 min is highly desirable, in order to shorten the classification time.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Stroke Triaging. After stroke occurrence, Time = Brain. Efficacy of care is correlated to a timely diagnosis and treatment. First, a CT/MRI scan is conducted to differentiate between an ischemic and hemorrhagic stroke. This is followed by stroke mechanisms (e.g., using the criteria of Trial of Org 10172 in Acute Stroke Treatment, TOAST classification) to identify a cardioembolic stroke. Patients with cardioembolic stroke harbor a higher risk of poorer stroke outcomes and timely treatment with acute reperfusion treatment is necessary (intravenous tissue plasminogen activator (IV-tPA)) within the time-limited window of 4.5 h. The ability to accurately measure stroke biomarkers (e.g., NT-proBNP and S100β) within 15 min is highly desirable, in order to shorten the classification time.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques: Biomarker Discovery

Stroke biomarkers measurement using bold SPR chip. ( A ) NT-proBNP; ( B ) S100β.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Stroke biomarkers measurement using bold SPR chip. ( A ) NT-proBNP; ( B ) S100β.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques:

Validation in spiked plasma samples. ( A ) NT-proBNP; ( B ) S100β.

Journal: Sensors (Basel, Switzerland)

Article Title: Point-of-Care Surface Plasmon Resonance Biosensor for Stroke Biomarkers NT-proBNP and S100β Using a Functionalized Gold Chip with Specific Antibody

doi: 10.3390/s19112533

Figure Lengend Snippet: Validation in spiked plasma samples. ( A ) NT-proBNP; ( B ) S100β.

Article Snippet: S100β protein (CAT#8S9b) and Anti-S100β 8B10 Antibody (CAT#4S37) were purchased from HyTest and used for the development of the biosensor for S100β detection.

Techniques: Biomarker Discovery, Clinical Proteomics